We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Researchers Construct Computer Simulations of Laser-Nanoparticle Treatments

By LabMedica International staff writers
Posted on 16 Jun 2009
Print article
Two lasers may be better than one when attacking cancer cells, according to a recent report.

Dr. Yildiz Bayazitoglu, a professor of mechanical engineering from Rice University (Houston, TX, USA) and a specialist on heat transfer and fluid flow, and doctoral student Jerry Vera are using computer simulations to quantify the effect of heating nanoparticles with near-infrared lasers to destroy cancer tumors without damaging healthy tissue.

The investigators hope to increase the effectiveness of destroying tumors by modifying methods of heating them based on the size and composition of not only the tumor but also the surrounding tissue. The study was published in the January 2009 issue of the International Journal of Heat and Mass Transfer.

The researchers revealed that attacking a tumor with two lasers could heat it more thoroughly than a single laser. For tumors as large as 1 cm, simulations showed opposing lasers surgically inserted via fiberoptics in a minimally invasive procedure generated the most uniform temperature profile in every case.

Lasers and nanoparticles are already being used to treat cancer. A company founded by Rice scientists Drs. Jennifer West and Naomi Halas, Nanospectra Biosciences, Inc. (Houston, TX, USA), is conducting human tests of a system that uses nanoshells heated by near-infrared lasers to kill tumors. Drs. Bayazitoglu, West, and Halas are all part of Rice's Laboratory for Nanophotonics.

The Bayazitoglu group's approach would refine such treatment by taking into account the light-scattering properties of nanoparticles. Their concern is that nanoparticles near the surface of a tumor will block a laser from reaching those at the center. "Think about it this way: If you're driving on a very foggy night, you can only see just so far no matter how good your headlights are,” commented Dr. Vera. "That's because the millions of small water droplets in the air absorb and scatter the light, deflecting the beams from your headlights before they can reflect off of whatever's ahead of you on the road. Nanoparticles dispersed within a tumor do exactly the same thing. They're very good at absorbing laser light and generating heat, but within particularly thick tumors, that same quality prevents a lot of the light from reaching deeper into the tissue.”

Dr. Bayazitoglu reported that this phenomenon, called "extinction,” is "highly undesirable.” A uniform temperature profile of at least 60 oC has to be created to kill the whole tumor. "Raising the temperature on one end but not the other will simply allow the tumor to regrow, and that doesn't solve the problem--or cure the patient.”

The density and placement of nanoparticles in the tumor are critical, according to Dr. Bayazitoglu. "Ideally, you should put nanoparticles at the center of the tumor, then kill it from the center out,” Dr. Bayazitoglu said.

Laser treatment may be effective even if nanoparticles are not used, she noted. "If the tumor has good absorption properties, slow heating can do a good job of killing the cancer, because the heat has time to get inside. If you're doing that, sometimes it's better not to use nanoparticles.”

With so many tissue types and the great range of cancers people face, the importance of accurate simulations cannot be overemphasized, according to the researchers. They hope the ability to calculate scenarios will allow clinicians to find the best laser therapy to produce the perfect heating environment.

Related Links:

Rice University
Nanospectra Biosciences

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Thyroid ELISA Kit
AESKULISA a-TPO
New
Laboratory Electric Thermostat
DNP-9025A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.